What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Surgery
His primary areas of investigation include Internal medicine, Heart failure, Cardiology, Transplantation and Surgery.
Randall C. Starling interconnects Heart disease, Renal function and Intensive care medicine in the investigation of issues within Heart failure.
The Heart disease study combines topics in areas such as Natriuretic peptide and Systole.
Ejection fraction, Ventricular assist device, Dilated cardiomyopathy, Myocarditis and Circulatory system are subfields of Cardiology in which his conducts study.
His research investigates the link between Transplantation and topics such as Disease that cross with problems in Evidence-based medicine.
His biological study spans a wide range of topics, including Clinical trial and Azathioprine.
His most cited work include:
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure (1008 citations)
- Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. (1002 citations)
- Effect of nesiritide in patients with acute decompensated heart failure. (942 citations)
What are the main themes of his work throughout his whole career to date?
Randall C. Starling spends much of his time researching Internal medicine, Cardiology, Heart failure, Transplantation and Surgery.
His Ejection fraction, Ventricular assist device, Heart transplantation and Acute decompensated heart failure study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines.
His study in Ischemic cardiomyopathy, Hemodynamics, Cardiomyopathy, Heart disease and Cardiac resynchronization therapy are all subfields of Cardiology.
His studies in Heart failure integrate themes in fields like Confidence interval, Hazard ratio, Ambulatory and Intensive care medicine.
His work carried out in the field of Transplantation brings together such families of science as Gastroenterology, Pathology, Intravascular ultrasound, Circulatory system and Vascular disease.
His specific area of interest is Surgery, where Randall C. Starling studies Randomized controlled trial.
He most often published in these fields:
- Internal medicine (67.01%)
- Cardiology (56.17%)
- Heart failure (43.02%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (67.01%)
- Cardiology (56.17%)
- Heart failure (43.02%)
In recent papers he was focusing on the following fields of study:
Randall C. Starling focuses on Internal medicine, Cardiology, Heart failure, Ventricular assist device and Ejection fraction.
Hazard ratio, Sacubitril, Valsartan, Interquartile range, Inotrope and Cohort are among the areas of Internal medicine where the researcher is concentrating his efforts.
Randall C. Starling conducted interdisciplinary study in his works that combined Cardiology and In patient.
His work in Heart failure addresses issues such as Intensive care medicine, which are connected to fields such as Transplantation.
His Ventricular assist device study combines topics in areas such as Stroke, Thrombosis, Coagulopathy and Implant.
His research in Ejection fraction intersects with topics in Cardiac function curve, Obesity and Diastole.
Between 2017 and 2021, his most popular works were:
- Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. (100 citations)
- The continuous heart failure spectrum: moving beyond an ejection fraction classification (75 citations)
- Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America. (51 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Surgery
Randall C. Starling spends much of his time researching Internal medicine, Heart failure, Cardiology, Ventricular assist device and Intensive care medicine.
Internal medicine is frequently linked to Multimodality in his study.
His study in Heart failure is interdisciplinary in nature, drawing from both Hemodynamics, Clinical trial and Hazard ratio.
His Cardiology study integrates concerns from other disciplines, such as Appropriate Use Criteria and Clinical endpoint.
His Ventricular assist device research includes elements of Stroke, Thrombosis, Coagulopathy and Implant.
His studies deal with areas such as Adverse effect, Transplantation and Consensus conference as well as Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
